109 results
8-K
EX-99.1
MBOT
Microbot Medical Inc.
17 Sep 24
Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024
8:30am
between Israel and the Palestinians and other neighboring countries, any lingering uncertainty resulting from the COVID-19 pandemic, need and ability
8-K
EX-99.1
MBOT
Microbot Medical Inc.
22 Aug 24
The agreement follows the successful completion of Phase 1 which evaluated the viability of LIBERTY as a remote telesurgery platform
8:30am
-19 pandemic, need and ability to obtain future capital, and maintenance of intellectual property rights. Additional information on risks facing
8-K
EX-99.1
MBOT
Microbot Medical Inc.
13 Aug 24
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
8:30am
and the Palestinians and other neighboring countries, any lingering uncertainty resulting from the COVID-19 pandemic, need and ability to obtain future
8-K
EX-99.1
MBOT
Microbot Medical Inc.
1 Aug 24
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
8:30am
the COVID-19 pandemic, need and ability to obtain future capital, and maintenance of intellectual property rights. Additional information on risks facing
8-K
EX-99.1
MBOT
Microbot Medical Inc.
18 Jul 24
Regulation FD Disclosure
8:30am
neighboring countries, any lingering uncertainty resulting from the COVID-19 pandemic, need and ability to obtain future capital, and maintenance
8-K
EX-99.1
mqi5ljo9
9 Jul 24
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
8:30am
8-K
EX-99.1
jfhll37b pxm
8 Jul 24
Regulation FD Disclosure
8:20am
8-K
EX-99.1
es9umml
3 Jul 24
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
8:20am
8-K
EX-99.1
ab8vxqu2exc794jt4p2h
17 Jun 24
Microbot Medical Announces Brigham and Women’s Hospital
8:30am
8-K
EX-99.2
761cic4xt4v
4 Jun 24
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:35pm
8-K
EX-99.1
s2mdsm5u s5na3hmf4x
4 Jun 24
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:35pm
424B5
5zylge
4 Jun 24
Prospectus supplement for primary offering
8:30am
8-K
EX-99.1
b7uvt2
3 Jun 24
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
8:20am
8-K
EX-99.1
4yi974sw0y7gpwx
29 Apr 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
ayyg7cmqbt f8h
15 Apr 24
Other Events
8:30am
8-K
EX-99.1
bdlblu dk34chgl
30 Jan 24
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
7:20am
8-K
EX-99.1
ili 15hvptounxwf74gp
18 Jan 24
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study
7:20am
8-K
EX-99.1
bee92
2 Jan 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-99.1
yi5wue3i
14 Dec 23
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic
8:15am
8-K
EX-99.1
nljqiub
7 Dec 23
The results of the study will support the Company’s IDE submission to the FDA to commence its human clinical study
8:00am